ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Total current assets

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.2B
P/E ratio
101.6x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 202618,813-37.43%
Mar 31, 202530,066-5.56%
Mar 31, 202431,836-4.79%
Mar 31, 202333,436-0.18%
Mar 31, 202233,495+10.01%
Mar 31, 202130,446+3.86%
Mar 31, 202029,314+2.25%
Mar 31, 201928,668+1.18%
Mar 31, 201828,334-2.33%
Mar 31, 201729,009+5.96%
Mar 31, 201627,378+10.20%
Mar 31, 201524,844

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat